TOLVAPTAN and CARDIAC FAILURE

785 reports of this reaction

3.2% of all TOLVAPTAN reports

#4 most reported adverse reaction

Overview

CARDIAC FAILURE is the #4 most commonly reported adverse reaction for TOLVAPTAN, manufactured by Otsuka America Pharmaceutical, Inc.. There are 785 FDA adverse event reports linking TOLVAPTAN to CARDIAC FAILURE. This represents approximately 3.2% of all 24,584 adverse event reports for this drug.

Patients taking TOLVAPTAN who experience cardiac failure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

CARDIAC FAILURE785 of 24,584 reports

CARDIAC FAILURE is moderately reported among TOLVAPTAN users, representing a notable but not dominant share of adverse events.

Other Side Effects of TOLVAPTAN

In addition to cardiac failure, the following adverse reactions have been reported for TOLVAPTAN:

DEATH — 973 reports
OFF LABEL USE — 814 reports
RENAL IMPAIRMENT — 804 reports
THIRST — 775 reports
PRODUCT DOSE OMISSION ISSUE — 522 reports
PRODUCT USE IN UNAPPROVED INDICATION — 487 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS — 480 reports
UNDERDOSE — 477 reports
DEHYDRATION — 449 reports
BLOOD CREATININE INCREASED — 422 reports

Other Drugs Associated with CARDIAC FAILURE

The following drugs have also been linked to cardiac failure in FDA adverse event reports:

BISOPROLOL FUMARATE DOPAMINE HYDROCHLORIDE DRONEDARONE EDOXABAN TOSYLATE EPLERENONE FEBUXOSTAT TABLETS 40 MG FEBUXOSTAT TABLETS 80 MG ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE IVABRADINE MEXILETINE HYDROCHLORIDE MILRINONE LACTATE PARICALCITOL SACUBITRIL AND VALSARTAN SPIRONOLACTONE TAFAMIDIS TETRAHYDROZOLINE HCL TORSEMIDE VONOPRAZAN FUMARATE WHITE PETROLEUM

Frequently Asked Questions

Does TOLVAPTAN cause CARDIAC FAILURE?

CARDIAC FAILURE has been reported as an adverse event in 785 FDA reports for TOLVAPTAN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is CARDIAC FAILURE with TOLVAPTAN?

CARDIAC FAILURE accounts for approximately 3.2% of all adverse event reports for TOLVAPTAN, making it a notable side effect.

What should I do if I experience CARDIAC FAILURE while taking TOLVAPTAN?

If you experience cardiac failure while taking TOLVAPTAN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

TOLVAPTAN Full Profile All Drugs Causing CARDIAC FAILURE Otsuka America Pharmaceutical, Inc. Drugs

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.